DRAKIVIO
"DRAKIVIO" is a word mark owned by Pfizer Inc., filed at the NIPO on April 7, 2026. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since May 9, 2026
- Filed
- April 7, 2026
- Registered
- May 9, 2026
- Expires
- April 7, 2036
- Application no.
- 202604335
- Registration no.
- 341767
- Office
- NIPO
- Patentstyret (Norwegian Industrial Property Office)
- Mark type
- Word mark
- 1 class
Who owns DRAKIVIO
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Pfizer Inc.
PFE · New York, United States
Representative
Bryn Aarflot AS
Bryn Aarflot AS
What the mark covers
The products and services DRAKIVIO is filed for, grouped by Nice class.
Farmasøytiske preparater.
What has happened so far
Steps recorded by the NIPO, newest first.
- Date of publication of a registered mark
About DRAKIVIO
Who owns the trademark "DRAKIVIO"?
The NIPO trademark "DRAKIVIO" (application 202604335) is owned by Pfizer Inc.
What is the status of "DRAKIVIO"?
Its status at the NIPO is: registered.
When was "DRAKIVIO" registered?
It was registered on May 9, 2026 and is due to expire on April 7, 2036.
Get this data via the API
Everything on this page comes from the Signa API. Pull DRAKIVIO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019e4be8-3d22-77aa-90a6-4e4462f95b72
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019e4be8-3d22-77aa-90a6-4e4462f95b72",
"object": "trademark",
"mark_text": "DRAKIVIO",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "NO",
"application_number": "202604335",
"filing_date": "2026-04-07",
"nice_classes": [
5
],
"owners": [
{
"name": "Pfizer Inc.",
"entity_id": "ent_019eb6f5-e620-74e3-b030-36986bcc1b4c"
}
]
}